Intravenous Iron: Measuring Response in Anemic Surgical Patients
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
20 Patients will be recruited with confirmed colorectal adenocarcinoma and anemia who are
planned to undergo surgery. All patients will be treated with a single dose of 1g intravenous
ferric carboxymaltose (FERINJECT).
It is hypothesized that intravenous iron supplementation is efficacious at raising
haemoglobin levels and reduced blood transfusion requirements.